rct
    2003
    High Quality

    Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age

    Braam LA, Knapen MH, Geusens P, Brouns F, Hamulyák K, Gerichhausen MJ, et al.

    Published in Calcif Tissue Int, Vol. 73 (1), pp. 21-6

    Methodology

    Three-year randomised, double-blind, placebo-controlled trial in 181 healthy postmenopausal women aged 50-60 (155 completed): placebo, a supplement of calcium, magnesium, zinc and vitamin D (8 mcg/day), or the same supplement with 1 mg/day vitamin K1.

    Key Findings

    The group given vitamin K1 with minerals and vitamin D lost less femoral neck bone density: 1.7% less than placebo (95% CI 0.35-3.44) and 1.3% less than minerals and vitamin D alone (95% CI 0.10-3.41). Lumbar spine bone density did not differ.

    Conclusions

    Given with minerals and vitamin D, vitamin K1 may reduce postmenopausal bone loss at the femoral neck.

    Limitations

    Effect at one of two primary sites; vitamin K1 was always given with a mineral and vitamin D supplement; healthy women without osteoporosis; no fracture outcomes.

    Supplements Studied

    Vitamin K1
    Vitamin

    vitamin K1 may substantially contribute to reducing postmenopausal bone loss at the site of the femoral neck

    Vitamin D
    Vitamin

    calcium, magnesium, zinc, and vitamin D (MD group)

    Calcium
    Mineral

    calcium, magnesium, zinc, and vitamin D (MD group)

    Outcomes Measured

    reduced bone loss of the femoral neck

    Related Health Concerns

    Study Details

    Year:2003
    Sample Size:181
    Duration:156 weeks
    Quality Score:7/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.